Turn Therapeutics Inc. — Form 8-K
Filed August 18, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
Turn Therapeutics filed an 8-K disclosing an unregistered sale of equity securities (Item 3.02) on August 13, 2026. The specific details—counterparties, dollar amounts, share count, and pricing—are not provided in this filing header. The company has $18.6M in total assets.
Why this rating
Without disclosed amounts/terms, cannot assess materiality. Unregistered equity sales are routine for biotech. Awaiting full filing details to evaluate impact on capital structure.
Extracted items
See more from August 18, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.